{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:6596"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:6596","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Changes in cellular phenotype and resistance to cisplatin in an oral squamous carcinoma model over-expressing cytoglobin","abstract":"Although cytoglobin is widely considered a tumour suppressor, re-expression plays a role in disease progression in a subset of oral squamous cell carcinomas (OSC), but the mechanism of action is not understood. In this thesis, we developed a new OSC cell model to study the effects of cytoglobin over­ expression on cellular phenotype and resistance to cisplatin. Microarray analysis of cytoglobin­ expressing cells showed significantly altered transcripts related to stress response, adhesion and locomotion, and metabolism. Treatment of cytoglobin-expressing cells with cisplatin revealed a greater response in p53-regulated target expression (MAP3K5, NQOl, CDKN2A and GADD45A) compared to non-expressing cells. Further investigation showed this was associated with higher CHKl, p53 and p21 protein levels, suggesting enhanced activation of p53 signalling pathways. Furthermore, cytoglobin-expressing cells were more resistant to cisplatin-induced apoptosis and altered their cell cycle distribution. These changes were linked to reduced total cellular and mitochondrial superoxide. Collectively, these findings demonstrate for the first time that cytoglobin over- expression is associated with resistance to cisplatin-induced cytotoxicity and the mechanism involves p53 signalling. In conclusion, we propose expression of cytoglobin may afford tumours cells a survival advantage in the harsh environmental conditions of the developing tumour as well as resistance to drugs like cisplatin.","abstract_html":"Although cytoglobin is widely considered a tumour suppressor, re-expression plays a role in disease progression in a subset of oral squamous cell carcinomas (OSC), but the mechanism of action is not understood. In this thesis, we developed a new OSC cell model to study the effects of cytoglobin over­ expression on cellular phenotype and resistance to cisplatin. Microarray analysis of cytoglobin­ expressing cells showed significantly altered transcripts related to stress response, adhesion and locomotion, and metabolism. Treatment of cytoglobin-expressing cells with cisplatin revealed a greater response in p53-regulated target expression (MAP3K5, NQOl, CDKN2A and GADD45A) compared to non-expressing cells. Further investigation showed this was associated with higher CHKl, p53 and p21 protein levels, suggesting enhanced activation of p53 signalling pathways. Furthermore, cytoglobin-expressing cells were more resistant to cisplatin-induced apoptosis and altered their cell cycle distribution. These changes were linked to reduced total cellular and mitochondrial superoxide. Collectively, these findings demonstrate for the first time that cytoglobin over- expression is associated with resistance to cisplatin-induced cytotoxicity and the mechanism involves p53 signalling. In conclusion, we propose expression of cytoglobin may afford tumours cells a survival advantage in the harsh environmental conditions of the developing tumour as well as resistance to drugs like cisplatin.","abstract_has_math":false,"creators":["Thorne, Lorna Susan"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2016,"date_issued":"2016-07","date_published":"2016-07","updated_at":"2026-11-19T09:28:58Z","subjects":["QR Microbiology"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/6596/1/Thorne16PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A6596","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["na"]},{"key":"dc:creator","label":"Author","values":["Thorne, Lorna Susan"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2016-07"]},{"key":"dc:date.issued","label":"Date","values":["2016-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Life & Environmental Sciences","School of Biosciences"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/6596/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QR Microbiology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/6596/1/Thorne16PhD.pdf","http://etheses.bham.ac.uk//id/eprint/6596/8/Decl_IS_Thorne16PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Although cytoglobin is widely considered a tumour suppressor, re-expression plays a role in disease progression in a subset of oral squamous cell carcinomas (OSC), but the mechanism of action is not understood. In this thesis, we developed a new OSC cell model to study the effects of cytoglobin over­ expression on cellular phenotype and resistance to cisplatin. Microarray analysis of cytoglobin­ expressing cells showed significantly altered transcripts related to stress response, adhesion and locomotion, and metabolism. Treatment of cytoglobin-expressing cells with cisplatin revealed a greater response in p53-regulated target expression (MAP3K5, NQOl, CDKN2A and GADD45A) compared to non-expressing cells. Further investigation showed this was associated with higher CHKl, p53 and p21 protein levels, suggesting enhanced activation of p53 signalling pathways. Furthermore, cytoglobin-expressing cells were more resistant to cisplatin-induced apoptosis and altered their cell cycle distribution. These changes were linked to reduced total cellular and mitochondrial superoxide. Collectively, these findings demonstrate for the first time that cytoglobin over- expression is associated with resistance to cisplatin-induced cytotoxicity and the mechanism involves p53 signalling. In conclusion, we propose expression of cytoglobin may afford tumours cells a survival advantage in the harsh environmental conditions of the developing tumour as well as resistance to drugs like cisplatin."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public","staffonly"]},{"key":"dc:title","label":"Title","values":["Changes in cellular phenotype and resistance to cisplatin in an oral squamous carcinoma model over-expressing cytoglobin"]}]}],"canonical_facts":{"dc:contributor.sponsor":["na"],"dc:creator":["Thorne, Lorna Susan"],"dc:date":["2016-07"],"dc:date.issued":["2016-07"],"dc:description.abstract":["Although cytoglobin is widely considered a tumour suppressor, re-expression plays a role in disease progression in a subset of oral squamous cell carcinomas (OSC), but the mechanism of action is not understood. In this thesis, we developed a new OSC cell model to study the effects of cytoglobin over­ expression on cellular phenotype and resistance to cisplatin. Microarray analysis of cytoglobin­ expressing cells showed significantly altered transcripts related to stress response, adhesion and locomotion, and metabolism. Treatment of cytoglobin-expressing cells with cisplatin revealed a greater response in p53-regulated target expression (MAP3K5, NQOl, CDKN2A and GADD45A) compared to non-expressing cells. Further investigation showed this was associated with higher CHKl, p53 and p21 protein levels, suggesting enhanced activation of p53 signalling pathways. Furthermore, cytoglobin-expressing cells were more resistant to cisplatin-induced apoptosis and altered their cell cycle distribution. These changes were linked to reduced total cellular and mitochondrial superoxide. Collectively, these findings demonstrate for the first time that cytoglobin over- expression is associated with resistance to cisplatin-induced cytotoxicity and the mechanism involves p53 signalling. In conclusion, we propose expression of cytoglobin may afford tumours cells a survival advantage in the harsh environmental conditions of the developing tumour as well as resistance to drugs like cisplatin."],"dc:format":["application/pdf"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/6596/1/Thorne16PhD.pdf","http://etheses.bham.ac.uk//id/eprint/6596/8/Decl_IS_Thorne16PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Life & Environmental Sciences","School of Biosciences"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/6596/"],"dc:subject":["QR Microbiology"],"dcterms:accessrights":["public","staffonly"],"dc:title":["Changes in cellular phenotype and resistance to cisplatin in an oral squamous carcinoma model over-expressing cytoglobin"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"]},"updated_at":"2026-11-19T09:28:58Z"}